Babylon Holdings Limited

Healthcare US BBLNF

0.0001USD
-(-%)

Last update at 2025-06-12T14:34:00Z

Day Range

0.00010.0001
LowHigh

52 Week Range

-0.0002
LowHigh

Fundamentals

  • Previous Close 0.0001
  • Market Cap0.00256M
  • Volume2499
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-248.88600M
  • Revenue TTM1154.34M
  • Revenue Per Share TTM56.49
  • Gross Profit TTM -17.85500M
  • Diluted EPS TTM-12.83

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Income before tax -221.51500M -375.98500M -183.39100M -145.84600M
Minority interest 0.00000M 6.03M - 0.00000M
Net income -221.44900M -368.48200M -188.03000M -140.28700M
Selling general administrative 227.94M 196.67M 92.65M 76.59M
Selling and marketing expenses - - - -
Gross profit 12.04M 33.25M 12.02M -3.77600M
Reconciled depreciation 12.05M 35.00M 14.49M 2.50M
Ebit -305.68600M -312.51500M -201.01000M -162.82000M
Ebitda -176.72900M -326.69000M -164.37400M -142.23400M
Depreciation and amortization - - - -
Non operating income net other - - - -
Operating income -336.99700M -402.50900M -175.51100M -162.82000M
Other operating expenses -31.31100M 46.53M 5.64M 2.32M
Interest expense 32.74M 14.29M 4.53M 1.12M
Tax provision -0.06600M -1.47400M 4.64M -5.55900M
Interest income 1.04M 0.33M 0.61M 1.01M
Net interest income -31.69500M -13.96500M -3.92000M -0.10100M
Extraordinary items - - - -
Non recurring - - - -
Other items - - - -
Income tax expense -0.06600M -1.44300M 4.64M -5.55900M
Total revenue 1109.67M 322.92M 79.27M 16.03M
Total operating expenses 1446.67M 725.43M 254.78M 178.85M
Cost of revenue 1097.63M 289.67M 67.25M 19.81M
Total other income expense net 147.18M 40.49M -3.96000M 17.07M
Discontinued operations - - - -
Net income from continuing ops -221.44900M -374.51100M -188.03000M -140.28700M
Net income applicable to common shares -221.44900M -77.40900M -211.79700M -140.28700M
Preferred stock and other adjustments - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Total assets 246.11M 554.63M 238.81M 288.83M
Intangible assets - 111.42M 78.85M 43.75M
Earning assets - - - -
Other current assets 133.76M 3.96M 5.16M -
Total liab 502.01M 389.36M 190.46M 115.04M
Total stockholder equity -255.89900M 165.27M 49.59M 173.80M
Deferred long term liab - 6.00M 50.78M 14.88M
Other current liab 118.81M 105.57M 31.69M 21.58M
Common stock 0.02M 0.01M 0.01000M 0.01000M
Capital stock 0.02M 0.02M 0.01M 0.01M
Retained earnings -836.77200M -615.32300M -469.50400M -282.70500M
Other liab 47.54M 267.43M 64.76M 64.89M
Good will 0.00000M 93.68M 17.83M 0.06M
Other assets - 6.00M 50.78M 14.88M
Cash 43.48M 262.58M 101.76M 214.89M
Cash and equivalents - - - -
Total current liabilities 162.39M 163.48M 123.68M 46.56M
Current deferred revenue - - - -
Net debt 234.55M - - -
Short term debt - - - -
Short long term debt - 0.18M 70.36M -
Short long term debt total - - - -
Other stockholder equity 4.27M -2.80800M 33.86M 13.36M
Property plant equipment 25.98M 37.77M 3.91M 7.03M
Total current assets 220.12M 312.68M 129.35M 237.99M
Long term investments - 0.00000M 8.88M 0.00000M
Net tangible assets -255.89900M -251.50500M 3.68M 144.86M
Short term investments - - - -
Net receivables 30.66M 24.56M 15.97M 18.26M
Long term debt 278.03M 168.60M - -
Inventory - - - -
Accounts payable 9.60M 17.18M 3.74M 5.19M
Total permanent equity - - - -
Noncontrolling interest in consolidated entity - - - -
Temporary equity redeemable noncontrolling interests - - - -
Accumulated other comprehensive income - - - -
Additional paid in capital - - - -
Common stock total equity - - - -
Preferred stock total equity - - - -
Retained earnings total equity - - - -
Treasury stock - - - -
Accumulated amortization - - - -
Non currrent assets other - - - -
Deferred long term asset charges - - - -
Non current assets total 25.98M 237.93M 109.47M 50.84M
Capital lease obligations 19.16M 12.63M 4.50M 3.58M
Long term debt total - - - -
Breakdown 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Type yearly yearly yearly yearly
Date 2022-12-31 2021-12-31 2020-12-31 2019-12-31
Investments -8.51400M -5.00000M -10.00000M -10.00000M
Change to liabilities 5.10M 44.77M 1.05M 18.05M
Total cashflows from investing activities -8.51400M -33.73300M -36.39000M -36.93600M
Net borrowings 100.00M 188.56M 100.00M 33.81M
Total cash from financing activities 173.18M 384.72M 101.85M 352.52M
Change to operating activities -11.54400M -20.55600M -5.82200M -5.82200M
Net income -221.44900M -77.40900M -211.79700M -140.28700M
Change in cash -219.10600M 160.82M -113.13100M 168.86M
Begin period cash flow 262.58M 101.76M 214.89M 46.03M
End period cash flow 43.48M 262.58M 101.76M 214.89M
Total cash from operating activities -311.40800M -189.44600M -180.48300M -143.61400M
Issuance of capital stock 80.00M 229.31M 12.10M 320.33M
Depreciation 11.35M 9.19M 3.96M 1.85M
Other cashflows from investing activities - - - 1.01M
Dividends paid - 0.00000M 0.00000M 0.00000M
Change to inventory - - - -
Change to account receivables -19.64300M -4.86800M 1.67M -9.30800M
Sale purchase of stock - - - -
Other cashflows from financing activities -6.82500M -33.15500M -10.24500M -1.62400M
Change to netincome -75.92100M -140.56600M 30.46M -14.56700M
Capital expenditures 8.51M 8.10M 0.72M 1.92M
Change receivables - - - -
Cash flows other operating - - - -
Exchange rate changes - - - -
Cash and cash equivalents changes - - - -
Change in working capital -26.08800M 25.67M 1.60M 8.74M
Stock based compensation 34.56M 46.31M 9.56M 7.97M
Other non cash items -155.98300M 162.69M 3.92M 0.10M
Free cash flow -319.92200M -186.09100M -180.65800M -181.56500M

Peer Comparison

Sector: Healthcare Industry: Health Information Services

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x)
BBLNF
Babylon Holdings Limited
- -% 0.0001 - - - - 0.25
GEHC
GE HealthCare Technologies Inc.
-0.13 0.18% 73.27 22.91 20.12 2.01 5.52 2.39 13.30
VEEV
Veeva Systems Inc Class A
-7.89 2.73% 280.66 54.61 33.22 12.83 6.73 11.14 58.84
MTHRF
M3 Inc
- -% 13.65 29.72 25.00 0.05 4.38 0.04 0.12
MTHRY
M3 Inc
-0.15 2.12% 6.92 31.84 26.25 0.05 4.60 0.04 0.12

Reports Covered

Stock Research & News

Profile

Babylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company provides Babylon Cloud and clinical services. Babylon Holdings Limited was founded in 2013 and is headquartered in Austin, Texas. On August 9, 2023, Babylon Inc., along with its affiliate, filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware.

Babylon Holdings Limited

2500 Bee Cave Road, Austin, TX, United States, 78746

Key Executives

Name Title Year Born
Dr. Ali Parsadoust Founder, Chairman & CEO 1966
Mr. Paul-Henri Ferrand Chief Operating Officer 1964
Mr. David Humphreys Chief Financial Officer 1977
Ms. Samira Lowman Chief People Officer NA
Ms. Mairi Johnson Chief Partnerships Officer & Employee Director 1967
Mr. Aron England Chief Product Officer NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes. This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API. Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.